Search
Gilead Sciences Inc
GILDAdd to Watchlist
166.890USD
-0.680-0.41%
Close 11-06 16:00（ET）
207.00BMarket Cap
22.51P/E TTM
After-hours 16:29 (ET)166.490USD-0.580-0.35%
After-hours 16:29 (ET)Gilead Sciences Inc (GILD) Stock Price Target & Forecast
Analyst Rating
Based on 30 analysts giving stock ratings to Gilead Sciences Inc in the past month.
Buy
7 Strong Buy
18 Buy
5 Hold
0 Sell
0 Strong Sell
Target Price
170.765USD+0.05%
GILD Analyst Recommendation Trends
In the current month, GILD has received 18 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. GILD average Analyst price target in the last month is 170.765.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
7
7
7
8
9
9
9
8
18
18
18
17
18
17
17
17
5
6
6
6
6
7
7
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
31
31
31
33
33
33
32
GILD Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Regeneron Pharmaceuticals Inc
REGN
6
15
9
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, GILD EPS is projected to reach 1.196 in FY2026Q4, following reported EPS of 1.956 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
1.91
-7.24
2.19
1.20
2.14
Actual
1.63
-8.44
1.96
--
--
Surprise
-14.99%
-16.71%
-10.54%
--
--
FAQs
What is Gilead Sciences Inc's expected revenue for the next quarter?
Gilead Sciences Inc's expected revenue is 8.35B.
What is Gilead Sciences Inc's price target?
Analysts forecast that Gilead Sciences Inc's price target is USD 171.76, with the highest forecast at USD 200.00 and the lowest forecast at USD 131.00.
How have Gilead Sciences IncGILD's recent earnings per share performed?
The market expectation was USD 1.96, while Gilead Sciences IncGILD's earnings per share (EPS) for the previous quarter was USD -8.44. EPS for the next quarter is expected at USD 1.20.
What is the analyst rating for Gilead Sciences Inc?
Based on the ratings of Gilead Sciences Inc's stock from 30 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.